SpectaCell publicly announced EUR 6 million in seed funding on Friday 9 October 2026, led by imec.xpand. The Belgian company combines research from imec, VIB and Ghent University in a platform that analyses how individual cells respond to treatments. Founded by Tony Montoye, Mathieu Rabaey, Veronique De Vroey and Jan Van de Velde, it is developing tools for drug development and manufacturing. SpectaCell says its imaging and data-analysis approach can provide clearer information about cell interactions. The financing supports platform development and commercialisation with pharmaceutical and biotechnology partners, bringing semiconductor expertise into the practical research requirements of advanced immune therapies.
SpectaCell launches with EUR 6m seed funding
imec.xpand leads investment in cell-analysis technology

Keep reading
More Funding

BrightAI secures USD 97 million to scale physical AI infrastructure
Smith Point Capital led the investment in sensor based monitoring for essential services.

Dcubed raises EUR 27.2 million to expand space hardware production
Warsaw Equity Group led the oversubscribed Series A plus round for the German manufacturer.

Linq raises USD 90 million to expand AI powered mobile infrastructure
Andreessen Horowitz led the Series B and partner Ben Horowitz joined the board.


